Literature DB >> 17096467

Depression is associated with low plasma Abeta42 independently of cardiovascular disease in the homebound elderly.

Wei Qiao Qiu1, Xiaoyan Sun, Dennis J Selkoe, D Mkaya Mwamburi, Tina Huang, Refeeque Bhadela, Peter Bergethon, Tammy M Scott, Paul Summergrad, Lixia Wang, Irwin Rosenberg, Marshal Folstein.   

Abstract

BACKGROUND: Depression often precedes the onset of Alzheimer's disease (AD) before the appearance of cognitive symptoms. Plasma Amyloid-beta peptide 42 (Abeta42) declines before and soon after the onset of AD, yet the relationship between plasma Abeta42 and depression is unclear.
METHODS: We used 515 homebound elders aged 60 and older in a population-based, cross-sectional study to investigate associations between plasma Abeta levels and depression with and without cardiovascular co-morbidities. Depression was evaluated by using the Center for Epidemiological Studies Depression (CES-D) scale. Plasma Abeta40 and Abeta42 were measured.
RESULTS: The elderly with depression had lower plasma Abeta42 (median: 15.3 vs. 18.9, p = 0.008) than those without depression. The CES-D score was inversely associated with plasma Abeta42 (p = 0.001) in subjects with no cardiovascular disease (CVD); however, in the presence of CVD, this association did not exist. Low plasma Abeta42 (OR = 0.41, p = 0.007) and the presence of CVD (OR = 1.84, p = 0.005) were independently associated with depression after adjusting for the confounders of age, stroke and apolipoprotein E4.
CONCLUSIONS: Depressive symptoms are associated with low plasma Abeta42 independently of CVD. Prospective studies are needed to determine whether depression associated with low plasma Abeta42 is a separate depression subtype that could predict the onset of AD. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17096467     DOI: 10.1002/gps.1710

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  23 in total

Review 1.  Physical and mental health of homebound older adults: an overlooked population.

Authors:  Wei Qiao Qiu; Michael Dean; Timothy Liu; Linda George; Margery Gann; Joshua Cohen; Martha L Bruce
Journal:  J Am Geriatr Soc       Date:  2010-11-10       Impact factor: 5.562

2.  Protein binding in patients with late-life depression.

Authors:  Anand Kumar; Vladimir Kepe; Jorge R Barrio; Prabha Siddarth; Vicki Manoukian; Virginia Elderkin-Thompson; Gary W Small
Journal:  Arch Gen Psychiatry       Date:  2011-11

3.  Soluble amyloid-β levels and late-life depression.

Authors:  Ricardo S Osorio; Tyler Gumb; Nunzio Pomara
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

4.  The relationship between plasma amyloid-β peptides and the medial temporal lobe in the homebound elderly.

Authors:  Xiaoyan Sun; Rafeeque Bhadelia; Elizabeth Liebson; Peter Bergethon; Marshal Folstein; Jay-Jiguang Zhu; D Mkaya Mwamburi; Samuel Patz; Wei Qiao Qiu
Journal:  Int J Geriatr Psychiatry       Date:  2010-12-09       Impact factor: 3.485

5.  Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.

Authors:  Sema Uslu; Zubeyde Eken Akarkarasu; Demet Ozbabalik; Serhat Ozkan; Omer Colak; Emine Sutken Demirkan; Ayşe Ozkiris; Canan Demirustu; Ozkan Alatas
Journal:  Neurochem Res       Date:  2012-03-22       Impact factor: 3.996

6.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

7.  Posterior Cingulate and Lateral Parietal Gray Matter Volume in Older Adults with Depressive Symptoms.

Authors:  Michele L Ries; Allison Wichmann; Barbara B Bendlin; Sterling C Johnson
Journal:  Brain Imaging Behav       Date:  2009-04-15       Impact factor: 3.978

8.  Antidepressants are a rational complementary therapy for the treatment of Alzheimer's disease.

Authors:  Marwa Aboukhatwa; Laura Dosanjh; Yuan Luo
Journal:  Mol Neurodegener       Date:  2010-03-12       Impact factor: 14.195

9.  The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.

Authors:  Haihao Zhu; Rafeeque A Bhadelia; Zhiheng Liu; Linh Vu; Huajie Li; Tammy Scott; Peter Bergethon; Mkaya Mwamburi; James L Rosenzweig; Irwine Rosenberg; Wei Qiao Qiu
Journal:  Angiology       Date:  2012-10-17       Impact factor: 3.619

10.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.